Target intelligence / Profile preview

Host innate immune and gut microbiota system

Molecular classification
Other
01

Overview

The host innate immune and gut microbiota system is a complex, bidirectional communication network that maintains physiological homeostasis and regulates immune responses. This system involves the interaction between commensal microorganisms in the gastrointestinal tract and the host's innate immune cells, such as macrophages, dendritic cells, and epithelial cells, primarily through pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) (Thaiss et al., 2016, Nature). The microbiota produces essential metabolites, including short-chain fatty acids (SCFAs), which modulate immune cell signaling and maintain the integrity of the intestinal barrier (Koh et al., 2016, Cell). Dysregulation of this crosstalk, often termed dysbiosis, is a key driver in the pathogenesis of inflammatory bowel diseases (IBD), metabolic disorders, and autoimmune conditions (Belkaid & Hand, 2014, Science). Furthermore, the composition of the gut microbiota has been shown to significantly influence the efficacy of systemic treatments, particularly cancer immunotherapies like immune checkpoint inhibitors (Gopalakrishnan et al., 2018, Science). Therapeutic interventions targeting this system aim to restore microbial balance and immune tolerance through the use of probiotics, prebiotics, and fecal microbiota transplantation (Khoruts & Sadowsky, 2016, Nature Reviews Gastroenterology & Hepatology).

Other names
Gut-immune axisMicrobiota-immune system crosstalkIntestinal immune systemGut-microbiome-immune axis
02

Mechanism of action

Modulation of microbial metabolites such as short-chain fatty acids, activation of pattern recognition receptors like Toll-like receptors, and maintenance of intestinal barrier integrity to regulate host inflammatory states.

03

Biological functions

Immune responseOther
04

Disease associations

InflammationCancerOther
05

Safety considerations

Risk of systemic infectionTransfer of multi-drug resistant organismsAntibiotic-induced dysbiosisUnpredictable therapeutic responsePotential for triggering autoimmune flares
06

Interacting drugs

Probiotics

7 more in the full profile.

07

Biomarkers

Fecal calprotectinMicrobial alpha diversityShort-chain fatty acid levelsAkkermansia muciniphila abundanceC-reactive protein

Beyond the preview

Go deeper on Host innate immune and gut microbiota system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host innate immune and gut microbiota system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call